05:09 GMT +325 June 2019
Listen Live
    Russian HIV vaccine has passed the second phase of clinical trial: Health Ministry

    Russian HIV Vaccine Passes 2nd Clinical Trial Phase, Health Ministry Says

    © Sputnik / Sergei Veniavskiy
    Russia
    Get short URL
    0 47

    Spokesperson for the Russian Health Ministry said that Russian HIV vaccine has passed the second phase of clinical trial.

    MOSCOW, January 22 (Sputnik) — Russian HIV vaccine has passed the second phase of clinical trial, Oleg Salagai, spokesperson for the Russian Health Ministry told journalists Thursday.

    In May 2014, during the Fourth Conference on HIV/AIDS in Eastern Europe and Central Asia, three prototypes of the candidate HIV vaccines were developed, according to the spokesperson.

    “All three medications have passed the first phase of clinical trials by now. For one of them the second phase of clinical trials has passed,” Salagai said.

    Currently, analysis of the clinical trial results is being carried out, the Ministry representative noted. After the analysis is completed, the development projects on HIV effective vaccines will continue.

    HIV, human immunodeficiency virus, causes AIDS, the acquired immunodeficiency syndrome. HIV infection is transferred with blood and other bodily fluids.

    According to the World Health Organization, 35 million of people were living with HIV and 1.5 million people died of HIV-related illnesses, as of December 2013. There is no effective HIV vaccine yet.

    Related:

    New HIV Prevention Medicine to Be Released Soon
    EU Reluctant to Join US Craze About HIV Prevention Pills
    Ebola Outbreak Worse than HIV, SARS: UN Health Expert
    Tags:
    vaccine, HIV, Russia
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik